Immunotherapeutic Strategies - Key Publications



Publications are listed according to year, with the most recent first. Within each year, publications are listed in alphabetical order, based on the first author’s surname. Click on “Publication link” to access the publication on PubMed. Use the search box above to find particular publications based on author or terms in the title.


  • The genotype of RAET1L (ULBP6), a ligand for human NKG2D (KLRK1), markedly influences the clinical outcome of allogeneic stem cell transplantation

    Antoun A, Vekaria D, Salama RA, Pratt G, Jobson S, Cook M, Briggs D, Moss P.

    Br J Haematol. 2012 Dec;159(5):589-98.

  • Chemokine-mediated tissue recruitment of CXCR3+ CD4+ T cells plays a major role in the pathogenesis of chronic GVHD

    Croudace JE, Inman CF, Abbotts BE, Nagra S, Nunnick J, Mahendra P, Craddock C, Malladi R, Moss PA.

    Blood. 2012 Nov 15;120(20):4246-55

  • Long-term proliferation of functional human NK cells, with conversion of CD56(dim) NK cells to a CD56 (bright) phenotype, induced by carcinoma cells co-expressing 4-1BBL and IL-12

    Dowell AC, Oldham KA, Bhatt RI, Lee SP, Searle PF.

    Cancer Immunol Immunother. 2012 May;61(5):615-28.

  • Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)

    Goodyear OC, Dennis M, Jilani NY, Loke J, Siddique S, Ryan G, Nunnick J, Khanum R, Raghavan M, Cook M, Snowden JA, Griffiths M, Russell N, Yin J, Crawley C, Cook G, Vyas P, Moss P, Malladi R, Craddock CF.

    Blood. 2012 Apr 5;119(14):3361-9.

  • Isotype and glycoform selection for antibody therapeutics

    Jefferis R.

    Arch Biochem Biophys. 2012 Oct 15;526(2):159-66.

  • Fibroblasts as therapeutic targets in rheumatoid arthritis and cancer.

    Juarez M, Filer A, Buckley CD.

    Swiss Med Wkly. 2012 Feb 24;142:w13529.